BioCentury | Feb 24, 2014
Clinical News

Bisantrene regulatory update

...was developed by Lederle Laboratories, part of American Cyanamid Co., which later merged with American Home Products Corp. American Home Products...
BioCentury | Oct 13, 2008
Company News

Wyeth infectious news

...The Supreme Court of Georgia ruled that Wyeth can be held liable for damages in American Home Products Corp....
...Wyeth said it will appeal to the U.S. Supreme Court. Marcelo and Carolyn Ferrari sued American Home Products...
BioCentury | Oct 9, 2008
Politics & Policy

Georgia court upholds Wyeth's liability for vaccine

...Supreme Court of Georgia ruled that Wyeth (NYSE:WYE) can be held liable for damages in American Home Products Corp....
...involving alleged defects in a vaccine. In 2002, Marcelo and Carolyn Ferrari sued Wyeth (then American Home Products...
BioCentury | Jun 4, 2007
Strategy

Big Thinkers revisited

...rather than by establishing biotech-like units. In 2000, when Bob Ruffolo joined WYE - then American Home Products Corp....
BioCentury | May 21, 2007
Finance

Ebb & Flow

...$789.4 million. Warburg Pincus, which created the company in 1999 via a leveraged buyout from American Home Products...
BioCentury | May 7, 2007
Finance

Ebb & Flow

...9). Eurand was formed in 1999 when Warburg Pincus acquired the drug delivery business of American Home Products...
BioCentury | Jul 17, 2006
Strategy

Biologic rebirth

...America and a manufacturing contract for the blockbuster Enbrel etanercept. One of the predecessor companies, American Home Products Corp....
BioCentury | Oct 17, 2005
Strategy

Vaccines getting hot

...infections and targets the seven most prevalent serotypes of pneumococcal bacteria. It was developed by American Home Products Corp....
BioCentury | May 30, 2005
Clinical News

Manhattan preclinical data

...lower homeostasis model assessment (HOMA) score. Data were published in the European Journal of Pharmacology. American Home Products Corp....
BioCentury | Jan 3, 2005
Strategy

Elan's $8B turnaround

...with the Phase II failure of AN-1792, a vaccine against AD that was partnered with American Home Products Corp....
Items per page:
1 - 10 of 431
BioCentury | Feb 24, 2014
Clinical News

Bisantrene regulatory update

...was developed by Lederle Laboratories, part of American Cyanamid Co., which later merged with American Home Products Corp. American Home Products...
BioCentury | Oct 13, 2008
Company News

Wyeth infectious news

...The Supreme Court of Georgia ruled that Wyeth can be held liable for damages in American Home Products Corp....
...Wyeth said it will appeal to the U.S. Supreme Court. Marcelo and Carolyn Ferrari sued American Home Products...
BioCentury | Oct 9, 2008
Politics & Policy

Georgia court upholds Wyeth's liability for vaccine

...Supreme Court of Georgia ruled that Wyeth (NYSE:WYE) can be held liable for damages in American Home Products Corp....
...involving alleged defects in a vaccine. In 2002, Marcelo and Carolyn Ferrari sued Wyeth (then American Home Products...
BioCentury | Jun 4, 2007
Strategy

Big Thinkers revisited

...rather than by establishing biotech-like units. In 2000, when Bob Ruffolo joined WYE - then American Home Products Corp....
BioCentury | May 21, 2007
Finance

Ebb & Flow

...$789.4 million. Warburg Pincus, which created the company in 1999 via a leveraged buyout from American Home Products...
BioCentury | May 7, 2007
Finance

Ebb & Flow

...9). Eurand was formed in 1999 when Warburg Pincus acquired the drug delivery business of American Home Products...
BioCentury | Jul 17, 2006
Strategy

Biologic rebirth

...America and a manufacturing contract for the blockbuster Enbrel etanercept. One of the predecessor companies, American Home Products Corp....
BioCentury | Oct 17, 2005
Strategy

Vaccines getting hot

...infections and targets the seven most prevalent serotypes of pneumococcal bacteria. It was developed by American Home Products Corp....
BioCentury | May 30, 2005
Clinical News

Manhattan preclinical data

...lower homeostasis model assessment (HOMA) score. Data were published in the European Journal of Pharmacology. American Home Products Corp....
BioCentury | Jan 3, 2005
Strategy

Elan's $8B turnaround

...with the Phase II failure of AN-1792, a vaccine against AD that was partnered with American Home Products Corp....
Items per page:
1 - 10 of 431